Small Caps
Faron Pharmaceuticals candidate gets FDA fast track designation
Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that its lead candidate, bexmarilimab, has been granted fast track designation by the US Food and Drug Administration (FDA), for the treatment of relapsed or refractory myelodysplastic syndrome (r/r MDS) in combination with azacitidine.
Prospex acquires 7.5pc stake in Viura gas field
Prospex Energy, an investment company focused on European gas and power projects, announced the successfully completed acquisition of a 7. 5% stake in Heyco Energy Iberia (HEI) on Tuesday, the majority owner of the Viura gas field in northern Spain.
Goldplat profitability improves in fourth quarter
South Africa and Ghana-focussed gold recovery specialist Goldplat announced a substantial increase in fourth-quarter profitability on Tuesday.
Diaceutics reports progress with rare-disease offerings
Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
Belluscura shares surge on strong sales momentum, improved outlook
Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full commercial launch of its new ‘DISCOV-R’ portable oxygen concentrator.
RUA Life Sciences reports strong start to financial year
RUA Life Sciences, a medical device company specialising in implantable textiles and biostable polymers, reported a strong start to its financial year on Tuesday, with trading in the first four months exceeding management expectations.
Shield Therapeutics iron deficiency treatment approved in Canada
Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that ‘ACCRUFeR’, or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).